Hair Dye Safety in Europe
This article was originally published in The Rose Sheet
Executive Summary
The Scientific Committee on Consumer Products publishes a memo March 29 notifying the European Commission of its finding that hair-dye ingredients have the potential to cause skin sensitization and allergic reactions. The memo provides "an authoritative overview of the current situation on the degree of sensitization potential of the assessed hair dye substances" and "indicates to the industry and to the research community that hair dyes need further innovative development in order to minimize potential adverse health effects to consumers," according to SCCP, which adopted the opinion during its 10th plenary meeting on Dec. 19, 2006. Though this is not the first time hair dyes have been subjected to SCCP's scrutiny, the committee's opinions to date have largely concerned the general toxicology of the substances...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.